While I believe Pfizer will rebound eventually, it will take some time to do so, and it may not occur in 2026. In the ...

In the assessment of 12-month price targets, analysts unveil insights for Medtronic, presenting an average target of $110.0, ...

Medtronic (MDT) is back in focus after William Blair upgraded the stock to Outperform, highlighting new product ramps tied to ...

The FDA designated the recall of certain Medtronic Bravo esophageal pH monitoring capsules as class I, the most serious type.

Medtronic disclosed Diabetes unit executive pay packages for 2025 and compensation targets for when they'll lead MiniMed as a ...

Medtronic this week launched its OmniaSecure defibrillation lead in the U.S., describing it as the world's smallest.

Medtronic has recalled certain DLP Left Heart Vent Catheters due to a defect that could cause serious injury or death. The recall applies to model numbers 12110, 12113 and 12115 with UDI-DIs ...

Investors looking for stocks in the Medical - Products sector might want to consider either Medtronic (MDT) or ...

If you are wondering whether Medtronic's current share price still offers value, this article will walk through what that ...

The filing comes about a month after competitor Medtronic won FDA approval for the Hugo robotic-assisted surgery system.

William Blair upgraded Medtronic, citing new product launches, FDA approvals, improving valuation, and clearer growth drivers ...

Medtronic (MDT) is a strong defensive investment with stable growth, 49 years of dividend increases, and fair value. Read here for more analysis.